Modern, antibiotic free treatment of vaginal infections Founded in 2015 in Lund, Sweden, Gedea Biotech is dedicated to developing safe and effective, antibiotic-free treatments for vaginal infections. Our lead product pHyph is an antibiotic free treatment for bacterial vaginosis that strengthens the healthy vaginal microbiome, supporting good vaginal health also in the long term. pHyph is approved for CE-mark has under EU MDR since 2025. The approval demonstrates the efficacy and safety of pHyph in treating bacterial vaginosis. We want to launch pHyph in partnership with pharmaceutical companies established in women’s health. pHyph is launch ready in Europe and in the US we want to enter a partnership for remaining clinical studies and launch. Gedea is privately held and backed by experienced life science investors. Its lead product pHyph represents a new standard of care in women’s health.
| Website | http://www.gedeabiotech.com |
| Revenue | $5.4 million |
| Employees | 15 (5 on RocketReach) |
| Founded | 2015 |
| Address | 2 Scheelevägen, Lund, Skane 223 81, SE |
| Phone | +46 70 891 86 81 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+9 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care |
| Keywords | Womens Health, Gynecological Health, Infectious Disease Treatment, Microbiome Therapeutics, Vaginal Health, Clinical Development, Drug Development, Biotechnology, Health Technology |
| Competitors | Thermo Fisher Scientific, Illumina, Roche, Siemens, Abbott, BD, bioMérieux, Cepheid, Hologic, Inc., Agilent Technologies +27 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Gedea Biotech AB employee's phone or email?
Gedea Biotech AB Questions
The Gedea Biotech AB annual revenue was $5.4 million in 2026.
Julie Brogren is the CEO of Gedea Biotech AB.
5 people are employed at Gedea Biotech AB.
Gedea Biotech AB is based in Lund, Skane.
The NAICS codes for Gedea Biotech AB are [541713, 541, 54171, 54, 5417].
The SIC codes for Gedea Biotech AB are [87, 873].
Top Gedea Biotech AB Employees
-
11
-
Per-Ola Forsberg
Chief Financial Officer at Gedea Biotech AB
Skåne County, Sweden1 -
11
-
Emilia Lahtinen
Doctoral Researcher at Gedea Biotech AB
Stockholm, SE1
Related Companies
